ADiTx Therapeutics, Inc. | Business Finance | Business Contracts

Second Amendment to Share Exchange Agreement by and between AiPharma Group Ltd. and Aditxt, Inc. dated June 10, 2022 (Filed With SEC on June 16, 2022)

Form of Placement Agent Warrant (Filed With SEC on June 15, 2022)

Inducement Offer to Exercise Series C Common Stock Purchase Warrants (Filed With SEC on June 15, 2022)

Form of Agreement for the Purchase and Sale of Future Receipts (Filed With SEC on June 3, 2022)

Amended and Restated Security Agreement between Cellvera Asia Limited and Aditxt, Inc. dated as of March 31, 2022 (Filed With SEC on May 16, 2022)

Forbearance Agreement and Eight Amendment to Secured Credit Agreement dated as of March 31, 2022 (Filed With SEC on May 16, 2022)

Underwriting Agreement between the Company and Dawson James Securities, Inc., dated December 1, 2021 (Filed With SEC on December 7, 2021)

Waiver and Defeasance Agreement (Filed With SEC on August 30, 2021)

Form of Registration Rights Agreement (Filed With SEC on January 26, 2021)

Form of Senior Secured Convertible Promissory Note (Filed With SEC on January 26, 2021)

Form of Private Placement Subscription Agreement (Filed With SEC on May 14, 2020)

Form of New Warrant (Filed With SEC on June 15, 2022)

Amendment No. 1 to Series C Warrant Agent Agreement dated June 15, 2022 (Filed With SEC on June 15, 2022)

Amendment to Share Exchange Agreement by and between AiPharma Group Ltd. and Aditxt, Inc. dated as of March 31, 2022 (Filed With SEC on May 16, 2022)

Security Agreement between Cellvera Global Holdings LLC and Aditxt, Inc. dated as of March 31, 2022 (Filed With SEC on May 16, 2022)

Security Agreement between Cellvera Development LLC and Aditxt, Inc. dated as of March 31, 2022 (Filed With SEC on May 16, 2022)

Security Agreement between Cellvera Holdings and Aditxt, Inc. dated as of March 31, 2022 (Filed With SEC on May 16, 2022)

Third Amendment to Secured Credit Agreement dated November 30, 2021, by and among AiPharma, AiPharma Holdings Limited, AiPharma Asia Limited and the Company (Filed With SEC on March 31, 2022)

Second Amendment to Secured Credit Agreement with AiPharma Global Holdings LLC dated October 27, 2021 (Filed With SEC on March 31, 2022)

Form of Warrant Reduction and Release Agreement dated as of November 24, 2021 (Filed With SEC on March 31, 2022)

Fifth Amendment to Secured Credit Agreement dated December 22, 2021, by and among AiPharma, AiPharma Holdings Limited, AiPharma Asia Limited and the Company (Filed With SEC on March 31, 2022)

Secured Credit Agreement, dated as of December 8, 2021, by and among the Company and the Target Company (Filed With SEC on March 31, 2022)

Sixth Amendment to Secured Credit Agreement dated December 28, 2021, by and among AiPharma, AiPharma Holdings Limited, AiPharma Asia Limited and the Company (Filed With SEC on March 31, 2022)

Forbearance Agreement and Seventh Amendment to Secured Credit Agreement dated as of February 14, 2022 by and among the Company, Cellvera Global Holdings LLC, Cellvera Holdings... (Filed With SEC on March 31, 2022)

Share Exchange Agreement dated as of December 28, 2021 by and between AiPharma Group Ltd. and Aditxt, Inc (Filed With SEC on December 28, 2021)

First Amendment to Secured Credit Agreement with AiPharma Global Holding LLC (Filed With SEC on November 15, 2021)

Security Agreement AiPharma Limited and Aditxt (BVI Law) (Filed With SEC on November 15, 2021)

Security Agreement, dated as of August 27, 2021 by and between AiPharma Limited and the Company (Filed With SEC on November 15, 2021)

Security Agreement, dated as of August 27, 2021 by and between AiPharma Asia Limited and the Company (Filed With SEC on November 15, 2021)

Secured Credit Agreement, dated as of August 27, 2021, by and among AiPharma, AiPharma Holdings Limited, AiPharma Asia Limited and the Company (Filed With SEC on November 15, 2021)

Underwriting Agreement between the Company and Revere Securities LLC dated October 18, 2021 (Filed With SEC on October 20, 2021)

Form of Securities Purchase Agreement (Filed With SEC on August 30, 2021)

Form of Placement Agent Warrant (Filed With SEC on August 30, 2021)

Form of Warrant (Filed With SEC on August 30, 2021)

Form of Placement Agent Warrant (Filed With SEC on January 26, 2021)

Form of Securities Purchase Agreement (Filed With SEC on January 26, 2021)

Form of Warrant (Filed With SEC on January 26, 2021)

Series B-1 Warrant Agent Agreement, including form of Series B-1 Warrant, dated September 4, 2020 (Filed With SEC on September 14, 2020)

Series A-1 Warrant Agent Agreement, including form of Series A-1 Warrant, dated September 4, 2020 (Filed With SEC on September 14, 2020)

Underwriting Agreement, dated September 1, 2020 (Filed With SEC on September 14, 2020)

Form of Underwriters Warrant (Filed With SEC on August 28, 2020)

Form of Series B-1 Warrant Agent Agreement (including the terms of the Series B-1 Warrant) (Filed With SEC on August 28, 2020)

Form of Series A-1 Warrant Agent Agreement (including the terms of the Series A-1 Warrant) (Filed With SEC on August 28, 2020)

Form of Underwriting Agreement (Filed With SEC on August 28, 2020)

Form of Series B Warrant Agent Agreement (including the terms of the Series B Warrant) (Filed With SEC on June 25, 2020)

Form of Series A Warrant Agent Agreement (including the terms of the Series A Warrant) (Filed With SEC on June 25, 2020)

Form of Underwriting Agreement (Filed With SEC on June 24, 2020)

Form of Underwriters Unit Purchase Option (Filed With SEC on June 24, 2020)

Form of Underwriters Unit Purchase Agreement (Filed With SEC on June 17, 2020)

Form of Underwriting Agreement (Filed With SEC on June 17, 2020)

Form of Warrant Agent Agreement (Filed With SEC on June 17, 2020)

Form of January 2020 Private Placement Promissory Note (Filed With SEC on May 14, 2020)

Form of January 2020 Note Purchase Agreement (Filed With SEC on May 14, 2020)

Form of October 2019 Note (Filed With SEC on May 14, 2020)

Form of October 2019 Securities Purchase Agreement (Filed With SEC on May 14, 2020)

Form of April 2018 Promissory Note (Filed With SEC on May 14, 2020)

Form of July 2018 Note (Filed With SEC on May 14, 2020)

Form of July 2018 Securities Purchase Agreement (Filed With SEC on May 14, 2020)

Warrant, dated March 8, 2018, issued to Sekris Biomedical, Inc (Filed With SEC on May 14, 2020)

Form of Promissory Note issued to Sekris Biomedical, Inc (Filed With SEC on May 14, 2020)

Form the Companys common stock certificate (Filed With SEC on May 14, 2020)

Form of March 2019 Promissory Note (Filed With SEC on May 14, 2020)

ADiTx Therapeutics, Inc. (87) | Business Finance (62)